Digoxin Immune Fab (Ovine) Completed Phase 4 Trials for Acute Kidney Injury (AKI) Prevention
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Prevention | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03810417 | Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI |